Amyloid-β peptide: Dr. Jekyll or Mr. Hyde?

Journal of Alzheimer's Disease

Volumn 33, Issue SUPPL. 1, 2013, Pages

  Puzzo, Daniela ^a   Arancio, Ottavio ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b NewYork Presbyterian Hospital   (United States)

Author keywords

Amyloid peptide; hippocampus; memory; nicotinic receptor; synaptic plasticity

Indexed keywords

AMPA RECEPTOR; AMYLOID BETA PROTEIN; AMYLOID BETA PROTEIN[1-42]; AMYLOID PRECURSOR PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NICOTINIC RECEPTOR; SMALL INTERFERING RNA;

ALZHEIMER DISEASE; CEREBROSPINAL FLUID; HIPPOCAMPUS; HUMAN; MEMORY DISORDER; NERVE CELL PLASTICITY; NEUROMODULATION; NEUROPATHOLOGY; NEUROTRANSMISSION; NONHUMAN; PRIORITY JOURNAL; REVIEW;

EID: 84870548539     PISSN: 13872877     EISSN: 18758908     Source Type: Journal    
DOI: 10.3233/JAD-2012-129033     Document Type: Review

References (115)

1. Glenner GG, Wong CW (1984) Alzheimer's disease: Initial report of the purification and characterization of a novel cerebrovascular amyloid protein. Biochem Biophys Res Commun 120, 885-890
2. Masters CL, Simms G,WeinmanNA, Multhaup G, McDonald BL, Beyreuther K (1985) Amyloid plaque core protein in Alzheimer disease and Down syndrome. Proc Natl Acad Sci U S A 82, 4245-4249
3. Kang J, Lemaire HG, Unterbeck A, Salbaum JM, Masters CL, Grzeschik KH, Multhaup G, Beyreuther K,M?uller-Hill B (1989) The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-Surface receptor. Nature 325, 733-736
4. Tanzi RE, Gusella JF, Watkins PC, Bruns GA, St George-Hyslop P, Van Keuren ML, Patterson D, Pagan S, Kurnit DM, Neve RL (1987) Amyloid beta protein gene: CDNA, mRNA distribution, and genetic linkage near the Alzheimer locus. Science 235, 880-884
5. Olson MI, Shaw CM (1969) Presenile dementia and Alzheimer's disease in mongolism. Brain 92, 147-156
6. Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., Van Duinen S.G., Bots G.T., Luyendijk W., Frangione B., Levy E., Carman M.D., Fernandez-Madrid I.J., Power M.D., Lieberburg I., Van Duinen S.G., Bots G.T., Luyendijk W., Frangione B.
7. Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science 248, 1124-1126
8. Chartier-Harlin MC, Crawford F, Houlden H, Warren A, Hughes D, Fidani L, Goate A, Rossor M, Roques P, Hardy J, et al. (1991) Early-onset Alzheimer's disease caused by mutations at codon 717 of the beta-Amyloid precursor protein gene. Nature 353, 844-846
9. Goate A, Chartier-Harlin MC, Mullan M, Brown J, Crawford F, Fidani L, Giuffra L, Haynes A, Irving N, James L, et al. (1991) Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease. Nature 349, 704-706
10. Levy E, Prelli F, Frangione B (2006) Studies on the first described Alzheimer's disease amyloid beta mutant, the Dutch variant. J Alzheimers Dis 9, 329-339
11. Di Fede G, Catania M, Morbin M, Rossi G, Suardi S, Mazzoleni G, Merlin M, Giovagnoli AR, Prioni S, Erbetta A, Falcone C, Gobbi M, Colombo L, Bastone A, BeegM, Manzoni C, Francescucci B, Spagnoli A, Cant̀u L, Del Favero E, Levy E, Salmona M, Tagliavini F (2009) A recessive mutation in the APP gene with dominant-Negative effect on amyloidogenesis. Science 323, 1473-1477
12. Spires TL, Hyman BT (2005) Transgenic models of Alzheimer's disease: Learning from animals. NeuroRx 2, 423-437
13. Holcomb L, Gordon MN, McGowan E, Yu X, Benkovic S, Jantzen P, Wright K, Saad I, Mueller R, Morgan D, Sanders S, Zehr C, O'Campo K, Hardy J, Prada CM, Eckman C, Younkin S, Hsiao K, Duff K (1998) Accelerated Alzheimertype phenotype in transgenic mice carrying both mutant amyloid precursor protein and presenilin 1 transgenes. Nat Med 4, 97-100
14. BlissTV, CollingridgeGL(1993)Asynaptic model of memory: Long-Term potentiation in the hippocampus. Nature 361, 31-39
15. Trinchese F, Liu S, Battaglia F, Walter S, Mathews PM, Arancio O (2004) Progressive age-related development of Alzheimer-Like pathology in APP/PS1 mice. Ann Neurol 55, 801-814
16. Cullen WK, Suh YH, Anwyl R, RowanMJ (1997) Block of LTP in rat hippocampus in vivo by beta-Amyloid precursor protein fragments. Neuroreport 8, 3213-3217
17. LambertMP, BarlowAK, Chromy BA, Edwards C, Freed R, Liosatos M, Morgan TE, Rozovsky I, Trommer B,Viola KL, Wals P, Zhang C, Finch CE, Krafft GA, Klein WL (1998) Diffusible, nonfibrillar ligands derived from Abeta1-42 are potent central nervous system neurotoxins. Proc Natl Acad Sci U S A 95, 6448-6453
18. Itoh A, Akaike T, Sokabe M, Nitta A, Iida R, Olariu A, Yamada K, Nabeshima T (1999) Impairments of long-Term potentiation in hippocampal slices of beta-Amyloid-infused rats. Eur J Pharmacol 382, 167-175
19. Chen QS, Kagan BL, Hirakura Y, Xie CW (2000) Impairment of hippocampal long-Term potentiation by Alzheimer amyloid beta-Peptides. J Neurosci Res 60, 65-72
20. Freir DB, Holscher C, Herron CE (2001) Blockade of longterm potentiation by beta-Amyloid peptides in the CA1 region of the rat hippocampus in vivo. J Neurophysiol 85, 708-713
21. Kim JH, Anwyl R, Suh YH, Djamgoz MB, Rowan MJ (2001) Use-Dependent effects of amyloidogenic fragments of (beta)-Amyloid precursor protein on synaptic plasticity in rat hippocampus in vivo. J Neurosci 21, 1327-1333
22. Malm T, Ort M, Táhtivaara L, Jukarainen N, Goldsteins G, Puoliváli J, Nurmi A, Pussinen R, Ahtoniemi T, Miettinen TK, Kanninen K, Leskinen S, Vartiainen N, Yrjánheikki J, Laatikainen R, Harris-White ME, Koistinaho M, Frautschy SA, Bures J, Koistinaho J (2006) Beta-Amyloid infusion results in delayed and age-Dependent learning deficits without role of inflammation or beta-Amyloid deposits. Proc Natl Acad Sci U S A 103, 8852-8857
23. Stephan A, Laroche S, Davis S (2001) Generation of aggregated beta-Amyloid in the rat hippocampus impairs synaptic transmission and plasticity and causes memory deficits. J Neurosci 21, 5703-5714
24. Vitolo OV, Sant'Angelo A, Costanzo V, Battaglia F, Arancio O, Shelanski M (2002) Amyloid-beta peptide inhibition of the PKA/CREB pathway and long-Term potentiation: Reversibility by drugs that enhance cAMP signaling. Proc Natl Acad Sci U S A 99, 13217-13221
25. Walsh DM, Klyubin I, Fadeeva JV, Cullen WK, Anwyl R, Wolfe MS, Rowan MJ, Selkoe DJ (2002) Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-Term potentiation in vivo. Nature 416, 535-539
26. Walsh DM, Klyubin I, Fadeeva JV, Rowan MJ, Selkoe DJ (2002) Amyloid-beta oligomers: Their production, toxicity and therapeutic inhibition. Biochem Soc Trans 30, 552-557
27. Cleary JP, Walsh DM, Hofmeister JJ, Shankar GM, Kuskowski MA, Selkoe DJ, Ashe KH (2005) Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat Neurosci 8, 79-84
28. Puzzo D, Vitolo O, Trinchese F, Jacob JP, Palmeri A, Arancio O (2005) Amyloid-beta peptide inhibits activation of the nitric oxide/cGMP/cAMP- responsive element-binding protein pathway during hippocampal synaptic plasticity. J Neurosci 25, 6887-6897
29. Shankar GM, Li S, Mehta TH, Garcia-Munoz A, Shepardson NE, Smith I, Brett FM, Farrell MA, Rowan MJ, Lemere CA, Regan CM,Walsh DM, Sabatini BL, Selkoe DJ (2008) Amyloid-beta protein dimers isolated directly from Alzheimer's brains impair synaptic plasticity and memory. Nat Med 14, 837-842
30. Puzzo D, Privitera L, Palmeri A (2012) Hormetic effect of amyloid-beta peptide in synaptic plasticity and memory. Neurobiol Aging 33, 1484.e15-24
31. Selkoe DJ (2002) Alzheimer's disease is a synaptic failure. Science 298, 789-791
32. Masliah E (1995) Mechanisms of synaptic dysfunction in Alzheimer's disease. Histol Histopathol 10, 509-519
33. Check E (2002) Nerve inflammation halts trial for Alzheimer's drug. Nature 415, 462
34. Nicoll JA, Wilkinson D, Holmes C, Steart P, Markham H, WellerRO(2003) Neuropathology of human Alzheimer disease after immunization with amyloid-beta peptide: A case report. Nat Med 9, 448-452
35. Fleisher AS, Raman R, Siemers ER, Becerra L, Clark CM, Dean RA, Farlow MR, Galvin JE, Peskind ER, Quinn JF, Sherzai A, Sowell BB, Aisen PS, Thal LJ (2008) Phase 2 safety trial targeting amyloid beta production with a gammasecretase inhibitor in Alzheimer disease. Arch Neurol 65, 1031-1038
36. Holmes C, Boche D, Wilkinson D, Yadegarfar G, Hopkins V, Bayer A, Jones RW, Bullock R, Love S, Neal JW, Zotova E, Nicoll JA (2008) Long-Term effects of Abeta42 immunisation in Alzheimer's disease: Follow-up of a randomised, placebo-controlled phase I trial. Lancet 372, 216-223
37. Green RC, Schneider LS, Amato DA, Beelen AP, Wilcock G, Swabb EA, Zavitz KH (2009) Effect of tarenflurbil on cognitive decline and activities of daily living in patients with mild Alzheimer disease:Arandomized controlled trial. JAMA 302, 2557-2564
38. Cummings J (2010) What can be inferred from the interruption of the semagacestat trial for treatment of Alzheimer's disease? Biol Psych 68, 876-878
39. Yankner BA, Duffy LK, Kirschner DA (1990) Neurotrophic and neurotoxic effects of amyloid beta protein: Reversal by tachykinin neuropeptides. Science 250, 279-282
40. Bishop GM, Robinson SR (2004) Physiological roles of amyloid-beta and implications for its removal in Alzheimer's disease. Drugs Aging 21, 621-630
41. Giuffrida ML, Caraci F, De Bona P, Pappalardo G, Nicoletti F, Rizzarelli E, Copani A (2010) The monomer state of beta-Amyloid: Where the Alzheimer's disease protein meets physiology. Rev Neurosci 21, 83-93
42. Luo Y, Sunderland T, Wolozin B (1996) Physiologic levels of beta-Amyloid activate phosphatidylinositol 3-kinase with the involvement of tyrosine phosphorylation. J Neurochem 67, 978-987
43. Giuffrida ML, Caraci F, Pignataro B, Cataldo S, De Bona P, BrunoV, Molinaro G, Pappalardo G, Messina A, Palmigiano A, Garozzo D, Nicoletti F, Rizzarelli E, Copani A (2009) Beta-Amyloid monomers are neuroprotective. J Neurosci 29, 10582-10587
44. Kontush A, Berndt C, Weber W, Akopyan V, Arlt S, Schippling S, Beisiegel U (2001) Amyloid- is an antioxidant for lipoproteins in cerebrospinal fluid and plasma. Free Radic Biol Med 30, 119-128
45. Butterfield DA (2002) Amyloid -Peptide(1-42)-induced oxidative stress and neurotoxicity: Implications for neurodegeneration in Alzheimer's disease brain: A review. Free Radic Res 36, 1307-1313
46. Baruch-Suchodolsky R, Fischer B (2009) Abeta40, either soluble or aggregated, is remarkably potent antioxidant in cell-free oxidative systems. Biochemistry 48, 4354-4370
47. Nadal RC, Rigby SE, Viles JH (2008) Amyloid beta-Cu2+complexes in both monomeric and fibrillar forms do not generate H2O2 catalytically but quench hydroxyl radicals. Biochemistry 47, 11653-11664
48. Robinson SR, Bishop GM (2002) A as a bioflocculant: Implications for the amyloid hypothesis of Alzheimer's disease. Neurobiol Aging 23, 1051-1072
49. Bishop GM, Robinson SR (2002) The amyloid hypothesis: Let sleeping dogmas lie? Neurobiol Aging 23, 1101-1105
50. L'opez-Toledano MA, Shelanski ML (2004) Neurogenic effect of beta-Amyloid peptide in the development of neural stem cells. J Neurosci 24, 5439-5444
51. Soscia SJ, Kirby JE,Washicosky KJ, Tucker SM, Ingelsson M, Hyman B, Burton MA, Goldstein LE, Duong S, Tanzi RE, Moir RD (2010) The Alzheimer's disease-Associated amyloid beta-Protein is an antimicrobial peptide. PLoS One 5, e9505
52. Dominguez D, Tournoy J, Hartmann D, Huth T, Cryns K, Deforce S, Serneels L, Camacho IE, Marjaux E, Craessaerts K, Roebroek AJ, Schwake M, D'Hooge R, Bach P, Kalinke U, Moechars D, Alzheimer C, Reiss K, Saftig P, De Strooper B (2005) Phenotypic and biochemical analyses of BACE1-And BACE2-Deficient mice. J Biol Chem 280, 30797-30806
53. Schmidt SD, Nixon RA, Mathews PM (2005) ELISA method for measurement of amyloid-beta levels. Methods Mol Biol 299, 279-297
54. Puzzo D, Privitera L, Leznik E, F̀a M, Staniszewski A, Palmeri A, Arancio O (2008) Picomolar amyloid-beta positively modulates synaptic plasticity and memory in hippocampus. J Neurosci 28, 14537-14545
55. Giedraitis V, Sundelöf J, Irizarry MC, Garevik N, Hyman BT, Wahlund LO, Ingelsson M, Lannfelt L (2007) The normal equilibrium between CSF and plasma amyloid beta levels is disrupted in Alzheimer's disease. Neurosci Lett 427, 127-131
56. Jensen M, Schröder J, BlombergM, Engvall B, Pantel J, Ida N, Basun H,Wahlund LO,Werle E, Jauss M, Beyreuther K, Lannfelt L, Hartmann T (1999) Cerebrospinal fluid Abeta42 is increased early in sporadic Alzheimer's disease and declines with disease progression. Ann Neurol 45, 504-511
57. Williams JH, Wilcock GK, Seeburger J, Dallob A, Laterza O, Potter W, Smith AD (2011) Non-Linear relationships of cerebrospinal fluid biomarker levels with cognitive function: An observational study. Alz Res Ther 3, 5
58. Blennow K (2004) Cerebrospinal fluid protein biomarkers for Alzheimer's disease. NeuroRx 1, 213-225
59. Brody DL, Magnoni S, Schwetye KE, Spinner ML, Esparza TJ, Stocchetti N, Zipfel GJ, HoltzmanDM(2008) Amyloidbeta dynamics correlate with neurological status in the injured human brain. Science 321, 1221-1224
60. Cirrito JR, Yamada KA, Finn MB, Sloviter RS, Bales KR, May PC, Schoepp DD, Paul SM, Mennerick S, Holtzman DM (2005) Synaptic activity regulates interstitial fluid amyloid-beta levels in vivo. Neuron 48, 913-922
61. Cirrito JR, Kang JE, Lee J, Stewart FR, Verges DK, Silverio LM, Bu G, Mennerick S, Holtzman DM (2008) Endocytosis is required for synaptic activity-Dependent release of amyloid-beta in vivo. Neuron 58, 42-51
62. Kamenetz F, Tomita T, Hsieh H, Seabrook G, Borchelt D, Iwatsubo T, Sisodia S, Malinow R. APP processing and synaptic function. Neuron 37, 925-937
63. Abramov E, Dolev I, Fogel H, Ciccotosto GD, Ruff E, Slutsky I (2009) Amyloid-beta as a positive endogenous regulator of release probability at hippocampal synapses. Nat Neurosci 12, 1567-1576
64. Mura E, Zappettini S, Preda S, Biundo F, Lanni C, Grilli M, Cavallero A, Olivero G, Salamone A, Govoni S, Marchi M (2012) Dual effect of beta-Amyloid on-7 and-4-2 nicotinic receptors controlling the release of glutamate, aspartate and GABA in rat hippocampus. PLoS One 7, e29661
65. Plant LD, Boyle JP, Smith IF, Peers C, Pearson HA (2003) The production of amyloid-beta peptide is a critical requirement for the viability of central neurons. J Neurosci 23, 5531-5535
66. Saura CA, Choi SY, Beglopoulos V, Malkani S, Zhang D, Shankaranarayana Rao BS, Chattarji S, Kelleher RJ III, Kandel ER, DuffK, Kirkwood A, Shen J (2004) Loss of presenilin function causes impairments of memory and synaptic plasticity followed by age-Dependent neurodegeneration. Neuron 42, 23-36
67. Wang H, Song L, Laird F,Wong PC, LeeHK(2008) BACE1 knock-outs display deficits in activity-Dependent potentiation of synaptic transmission at mossy fiber to CA3 synapses in the hippocampus. J Neurosci 28, 8677-8681
68. Laird FM, Cai H, Savonenko AV, Farah MH, He K, Melnikova T,Wen H, Chiang HC, Xu G, Koliatsos VE, Borchelt DR, Price DL, Lee HK, Wong PC (2005) BACE1, a major determinant of selective vulnerability of the brain to amyloid-Amyloidogenesis, is essential for cognitive, emotional, and synaptic functions. J Neurosci 25, 11693-11709
69. Harrison SM, Harper AJ, Hawkins J, Duddy G, Grau E, Pugh PL, Winter PH, Shilliam CS, Hughes ZA, Dawson LA, Gonzalez MI, Upton N, Pangalos MN, Dingwall C (2003) BACE1 (beta-Secretase) transgenic and knockout mice: Identification of neurochemical deficits and behavioral changes. Mol Cell Neurosci 24, 646-655
70. M?uller U, Cristina N, Li ZW, Wolfer DP, Lipp HP, R?ulicke T, Brandner S, Aguzzi A, Weissmann C (1994) Behavioral and anatomical deficits in mice homozygous for a modified beta-Amyloid precursor protein gene. Cell 79, 755-765
71. Zheng H, Jiang M, Trumbauer ME, Sirinathsinghji DJ, Hopkins R, Smith DW, Heavens RP, Dawson GR, Boyce S, Conner MW, Stevens KA, Slunt HH, Sisoda SS, Chen HY, Van der Ploeg LH (1995) Beta-Amyloid precursor protein-Deficient mice show reactive gliosis and decreased locomotor activity. Cell 81, 525-531
72. Dawson GR, Seabrook GR, Zheng H, Smith DW, Graham S, O'Dowd G, Bowery BJ, Boyce S, Trumbauer ME, Chen HY, Van der Ploeg LH, Sirinathsinghji DJ (1999) Agerelated cognitive deficits, impaired long-Term potentiation and reduction in synaptic marker density in mice lacking the beta-Amyloid precursor protein. Neuroscience 90, 1-13
73. Phinney AL, Calhoun ME, Wolfer DP, Lipp HP, Zheng H, Jucker M (1999) No hippocampal neuron or synaptic bouton loss in learning-impaired aged beta-Amyloid precursor protein-Null mice. Neuroscience 90, 1207-1216
74. Seabrook GR, SmithDW, Bowery BJ, Easter A, Reynolds T, Fitzjohn SM,Morton RA, Zheng H, Dawson GR, Sirinathsinghji DJ, Davies CH, Collingridge GL, Hill RG (1999) Mechanisms contributing to the deficits in hippocampal synaptic plasticity in mice lacking amyloid precursor protein. Neuropharmacology 38, 349-359
75. Ring S, Weyer SW, Kilian SB, Waldron E, Pietrzik CU, Filippov MA, Herms J, Buchholz C, Eckman CB, Korte M, Wolfer DP, M?uller UC (2007) The secreted beta-Amyloid precursor protein ectodomain APPs alpha is sufficient to rescue the anatomical, behavioral, and electrophysiological abnormalities of APP-Deficient mice. J Neurosci 27, 7817-7826
76. Araki W, Kitaguchi N, Tokushima Y, Ishii K, Aratake H, Shimohama S, Nakamura S, Kimura J (1991) Trophic effect of beta-Amyloid precursor protein on cerebral cortical neurons in culture. Biochem Biophys Res Commun 181, 265-271
77. Huber G, Martin JR, Löffler J, Moreau JL (1993) Involvement of amyloid precursor protein in memory formation in the rat: An indirect antibody approach. Brain Res 603, 348-352
78. Mattson MP (1994) Secreted forms of beta-Amyloid precursor protein modulate dendrite outgrowth and calcium responses to glutamate in cultured embryonic hippocampal neurons. J Neurobiol 25, 439-450
79. Mucke L, Masliah E, Johnson WB, Ruppe MD, Alford M, Rockenstein EM, Forss-Petter S, Pietropaolo M, Mallory M, Abraham CR (1994) Synaptotrophic effects of human amyloid beta protein precursors in the cortex of transgenic mice. Brain Res 666, 151-167
80. Smith-Swintosky VL, Pettigrew LC, Craddock SD, Culwell AR, Rydel RE, Mattson MP (1994) Secreted forms of betaamyloid precursor protein protect against ischemic brain injury. J Neurochem 63, 781-784
81. Furukawa K, Sopher BL, Rydel RE, Begley JG, Pham DG, Martin GM, Fox M, Mattson MP (1996) Increased activityregulating and neuroprotective efficacy of alpha-Secretasederived secreted amyloid precursor protein conferred by a C-Terminal heparin-binding domain. J Neurochem 67, 1882-1896
82. Ishida A, Furukawa K, Keller JN, Mattson MP (1997) Secreted form of beta-Amyloid precursor protein shifts the frequency dependency for induction of LTD, and enhances LTP in hippocampal slices. Neuroreport 8, 2133-2137
83. Meziane H, Dodart JC, Mathis C, Little S, Clemens J, Paul SM, Ungerer A (1998) Memory-enhancing effects of secreted forms of the beta-Amyloid precursor protein in normal and amnestic mice. Proc Natl Acad Sci U S A 95, 12683-12688
84. Mileusnic R, Lancashire CL, Johnston AN, Rose SP (2000) APP is required during an early phase of memory formation. Eur J Neurosci 12, 4487-4495
85. Cao X, Sudhof TC (2001) A transcriptionally active complex of APP with Fe65 and histone acetyltransferase Tip60. Science 293, 115-120
86. Gao Y, Pimplikar SW (2001) The gamma-Secretase-cleaved C-Terminal fragment of amyloid precursor protein mediates signaling to the nucleus. Proc Natl Acad SciUSA98, 14979-14984
87. Kimberly WT, Zheng JB, Gu'enette SY, Selkoe DJ (2001) The intracellular domain of the beta-Amyloid precursor protein is stabilized by Fe65 and translocates to the nucleus in a notch-Like manner. J Biol Chem 276, 40288-40292
88. Leissring MA, Murphy MP, Mead TR, Akbari Y, Sugarman MC, Jannatipour M, Anliker B, M?uller U, Saftig P, De Strooper B, Wolfe MS, Golde TE, LaFerla FM (2002) A physiologic signaling role for the gamma- secretasederived intracellular fragment of APP. Proc Natl Acad Sci U S A 99, 4697-4702
89. Ma H, Lesn'e S, Kotilinek L, Steidl-Nichols JV, Sherman M, Younkin L, Younkin S, Forster C, Sergeant N, Delacourte A, Vassar R, Citron M, Kofuji P, Boland LM, Ashe KH (2007) Involvement of beta-Site APP cleaving enzyme 1 (BACE1) in amyloid precursor protein-Mediated enhancement of memory and activity-Dependent synaptic plasticity. Proc Natl Acad Sci U S A 104, 8167-8172
90. Lisman J, Raghavachari S (2006) A unified model of the presynaptic and postsynaptic changes during LTP at CA1 synapses. Sci STKE 2006(356), re11
91. Zucker RS, Regehr WG (2002) Short-Term synaptic plasticity. Annu Rev Physiol 64, 355-405
92. Albuquerque EX, Pereira EF, Alkondon M, Rogers SW (2009) Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 89, 73-120
93. Levey AI (1996) Muscarinic acetylcholine receptor expression in memory circuits: Implications for treatment of Alzheimer disease. Proc Natl Acad Sci U S A 93, 13541-13546
94. Levin ED (2002) Nicotinic receptor subtypes and cognitive function. J Neurobiol 53, 633-640
95. CladerJW,WangY(2005) Muscarinic receptor agonists and antagonists in the treatment of Alzheimer's disease. Curr Pharm Des 11, 3353-3361
96. Oddo S, LaFerla FM (2006) The role of nicotinic acetylcholine receptors in Alzheimer's disease. J Physiol Paris 99, 172-179
97. Jones S, Sudweeks S, Yakel JL (1999) Nicotinic receptors in the brain: Correlating physiology with function. Trends Neurosci 22, 555-561
98. Levin ED, Simon BB (1998) Nicotinic acetylcholine involvement in cognitive function in animals. Psychopharmacology (Berl) 138, 217-230
99. Ji D, Lape R, Dani JA (2001) Timing and location of nicotinic activity enhances or depresses hippocampal synaptic plasticity. Neuron 31, 131-141
100. Gray R, Rajan AS, Radcliffe KA, Yakehiro M, Dani JA (1996) Hippocampal synaptic transmission enhanced by low concentrations of nicotine. Nature 383, 713-716
101. Radcliffe KA, Dani JA (1998) Nicotinic stimulation produces multiple forms of increased glutamatergic synaptic transmission. J Neurosci 18, 7075-7083
102. Genzen JR, McGehee DS (2003) Short- And long-Term enhancement of excitatory transmission in the spinal cord dorsal horn by nicotinic acetylcholine receptors. Proc Natl Acad Sci U S A 100, 6807-6812
103. Girod R, Barazangi N, McGehee D, Role LW(2000) Facilitation of glutamatergic neurotransmission by presynaptic nicotinic acetylcholine receptors. Neuropharmacology 39, 2715-2725
104. Ondrejcak T, Klyubin I, Hu NW, Barry AE, Cullen WK, RowanMJ (2010) Alzheimer's disease amyloid beta-Protein and synaptic function. Neuromol Med 12, 13-26
105. Feh'er A, Juh'asz A, Riman'oczy A, Csibri E,K'alm'an J, Janka Z (2009) Association between a genetic variant of the alpha-7 nicotinic acetylcholine receptor subunit and four types of dementia. Dement Geriatr Cogn Disord 28, 56-62
106. Wang HY, Lee DH, D'Andrea MR, Peterson PA, Shank RP, Reitz AB (2000) Beta-Amyloid(1-42) binds to alpha7 nicotinic acetylcholine receptor with high affinity. Implications for Alzheimer's disease pathology. J Biol Chem 275, 5626-5632
107. Small DH, Maksel D, Kerr ML, Ng J, Hou X, Chu C, Mehrani H, Unabia S, Azari MF, Loiacono R, Aguilar MI, Chebib M (2007) The beta-Amyloid protein of Alzheimer's disease binds to membrane lipids but does not bind to the alpha7 nicotinic acetylcholine receptor. J Neurochem 101, 1527-1538
108. Khan GM, Tong M, Jhun M, Arora K, Nichols RA (2010) Beta-Amyloid activates presynaptic alpha7 nicotinic acetylcholine receptors reconstituted into a model nerve cell system: Involvement of lipid rafts. Eur J Neurosci 31, 788-796
109. Dougherty JJ,Wu J, Nichols RA (2003) Beta-Amyloid regulation of presynaptic nicotinic receptors in rat hippocampus and neocortex. J Neurosci 23, 6740-6747
110. Fodero LR, Mok SS, Losic D, Martin LL, Aguilar MI, Barrow CJ, Livett BG, Small DH (2004) Alpha7-Nicotinic acetylcholine receptors mediate an Abeta(1-42)-induced increase in the level of acetylcholinesterase in primary cortical neurones. J Neurochem 88, 1186-1193
111. Grassi F, Palma E, Tonini R, Amici M, Ballivet M, Eusebi F (2003) Amyloid beta(1-42) peptide alters the gating of human and mouse alpha-bungarotoxin- Sensitive nicotinic receptors. J Physiol 547, 147-157
112. Dineley KT, Bell KA, Bui D, Sweatt JD (2002) Betaamyloid peptide activates alpha 7 nicotinic acetylcholine receptors expressed in Xenopus oocytes. J Biol Chem 277, 25056-25061
113. Puzzo D, Privitera L, Fa'M, Staniszewski A, Hashimoto G, Aziz F, Sakurai M, Ribe EM, Troy CM, Mercken M, Jung SS, Palmeri A, Arancio O (2011) Endogenous amyloid- is necessary for hippocampal synaptic plasticity and memory. Ann Neurol 69, 819-830
114. Garcia-Osta A, Alberini CM (2009) Amyloid beta mediates memory formation. Learn Mem 16, 267-272
115. Morley JE, Farr SA, Banks WA, Johnson SN, Yamada KA, Xu L (2010) A physiological role for amyloid-beta protein: Enhancement of learning and memory. J Alzheimers Dis 19, 441-449